Literature DB >> 22962404

A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma.

Xiangqing Sun1, Jaime Vengoechea, Robert Elston, Yanwen Chen, Christopher I Amos, Georgina Armstrong, Jonine L Bernstein, Elizabeth Claus, Faith Davis, Richard S Houlston, Dora Il'yasova, Robert B Jenkins, Christoffer Johansen, Rose Lai, Ching C Lau, Yanhong Liu, Bridget J McCarthy, Sara H Olson, Siegal Sadetzki, Joellen Schildkraut, Sanjay Shete, Robert Yu, Nicholas A Vick, Ryan Merrell, Margaret Wrensch, Ping Yang, Beatrice Melin, Melissa L Bondy, Jill S Barnholtz-Sloan.   

Abstract

BACKGROUND: We propose a 2-step model-based approach, with correction for ascertainment, to linkage analysis of a binary trait with variable age of onset and apply it to a set of multiplex pedigrees segregating for adult glioma.
METHODS: First, we fit segregation models by formulating the likelihood for a person to have a bivariate phenotype, affection status and age of onset, along with other covariates, and from these we estimate population trait allele frequencies and penetrance parameters as a function of age (N = 281 multiplex glioma pedigrees). Second, the best fitting models are used as trait models in multipoint linkage analysis (N = 74 informative multiplex glioma pedigrees). To correct for ascertainment, a prevalence constraint is used in the likelihood of the segregation models for all 281 pedigrees. Then the trait allele frequencies are reestimated for the pedigree founders of the subset of 74 pedigrees chosen for linkage analysis.
RESULTS: Using the best-fitting segregation models in model-based multipoint linkage analysis, we identified 2 separate peaks on chromosome 17; the first agreed with a region identified by Shete and colleagues who used model-free affected-only linkage analysis, but with a narrowed peak: and the second agreed with a second region they found but had a larger maximum log of the odds (LOD).
CONCLUSIONS: Our approach was able to narrow the linkage peak previously published for glioma. IMPACT: We provide a practical solution to model-based linkage analysis for disease affection status with variable age of onset for the kinds of pedigree data often collected for linkage analysis.

Entities:  

Mesh:

Year:  2012        PMID: 22962404      PMCID: PMC3518573          DOI: 10.1158/1055-9965.EPI-12-0703

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  18 in total

1.  The affected-/discordant-sib-pair design can guarantee validity of multipoint model-free linkage analysis of incomplete pedigrees when there is marker-marker disequilibrium.

Authors:  Chao Xing; Ritwik Sinha; Guan Xing; Qing Lu; Robert C Elston
Journal:  Am J Hum Genet       Date:  2006-06-26       Impact factor: 11.025

2.  Ascertainment correction for Markov chain Monte Carlo segregation and linkage analysis of a quantitative trait.

Authors:  Jianzhong Ma; Christopher I Amos; E Warwick Daw
Journal:  Genet Epidemiol       Date:  2007-09       Impact factor: 2.135

Review 3.  GLIOGENE an International Consortium to Understand Familial Glioma.

Authors:  Beatrice Malmer; Phyllis Adatto; Georgina Armstrong; Jill Barnholtz-Sloan; Jonine L Bernstein; Elizabeth Claus; Faith Davis; Richard Houlston; Dora Il'yasova; Robert Jenkins; Christoffer Johansen; Rose Lai; Ching Lau; Bridget McCarthy; Hanne Nielsen; Sara H Olson; Siegal Sadetzki; Sanjay Shete; Fredrik Wiklund; Margaret Wrensch; Ping Yang; Melissa Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-09       Impact factor: 4.254

4.  Markov chain Monte Carlo segregation and linkage analysis for oligogenic models.

Authors:  S C Heath
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

5.  Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium.

Authors:  Sanjay Shete; Ching C Lau; Richard S Houlston; Elizabeth B Claus; Jill Barnholtz-Sloan; Rose Lai; Dora Il'yasova; Joellen Schildkraut; Siegal Sadetzki; Christoffer Johansen; Jonine L Bernstein; Sara H Olson; Robert B Jenkins; Ping Yang; Nicholas A Vick; Margaret Wrensch; Faith G Davis; Bridget J McCarthy; Eastwood Hon-chiu Leung; Caleb Davis; Rita Cheng; Fay J Hosking; Georgina N Armstrong; Yanhong Liu; Robert K Yu; Roger Henriksson; Beatrice S Melin; Melissa L Bondy
Journal:  Cancer Res       Date:  2011-10-28       Impact factor: 12.701

6.  Genetic epidemiology of coeliac disease.

Authors:  J L Tiwari; H Betuel; L Gebuhrer; N E Morton
Journal:  Genet Epidemiol       Date:  1984       Impact factor: 2.135

7.  After hMSH2 and hMLH1--what next? Analysis of three-generational, population-based, early-onset colorectal cancer families.

Authors:  Mark A Jenkins; Laura Baglietto; Gillian S Dite; Damien J Jolley; Melissa C Southey; Jonathan Whitty; Leeanne J Mead; D James B St John; Finlay A Macrae; D Timothy Bishop; Deon J Venter; Graham G Giles; John L Hopper
Journal:  Int J Cancer       Date:  2002-11-10       Impact factor: 7.396

8.  Homozygosity mapping of familial glioma in Northern Sweden.

Authors:  Beatrice Malmer; Susann Haraldsson; Elisabet Einarsdottir; Petter Lindgren; Dan Holmberg
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089

9.  Genetic etiology of gastric carcinoma: I. Chronic atrophic gastritis.

Authors:  G E Bonney; R C Elston; P Correa; W Haenszel; D E Zavala; G Zarama; T Collazos; C Cuello
Journal:  Genet Epidemiol       Date:  1986       Impact factor: 2.135

10.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

View more
  8 in total

Review 1.  The epidemiology of glioma in adults: a "state of the science" review.

Authors:  Quinn T Ostrom; Luc Bauchet; Faith G Davis; Isabelle Deltour; James L Fisher; Chelsea Eastman Langer; Melike Pekmezci; Judith A Schwartzbaum; Michelle C Turner; Kyle M Walsh; Margaret R Wrensch; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

2.  Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial Paradigm.

Authors:  Xiangqing Sun; Robert C Elston; Jill S Barnholtz-Sloan; Gary W Falk; William M Grady; Ashley Faulx; Sumeet K Mittal; Marcia Canto; Nicholas J Shaheen; Jean S Wang; Prasad G Iyer; Julian A Abrams; Ye D Tian; Joseph E Willis; Kishore Guda; Sanford D Markowitz; Apoorva Chandar; James M Warfe; Wendy Brock; Amitabh Chak
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02-29       Impact factor: 4.254

3.  Genome-wide analysis of high-risk primary brain cancer pedigrees identifies PDXDC1 as a candidate brain cancer predisposition gene.

Authors:  Lisa A Cannon-Albright; James M Farnham; Jeffrey Stevens; Craig C Teerlink; Cheryl A Palmer; Kerry Rowe; Melissa H Cessna; Deborah T Blumenthal
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

4.  Targeted sequencing in chromosome 17q linkage region identifies familial glioma candidates in the Gliogene Consortium.

Authors:  Ali Jalali; E Susan Amirian; Matthew N Bainbridge; Georgina N Armstrong; Yanhong Liu; Spyros Tsavachidis; Shalini N Jhangiani; Sharon E Plon; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Dora Il'yasova; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Christoffer Johansen; Richard S Houlston; Robert B Jenkins; Daniel Lachance; Sara H Olson; Jonine L Bernstein; Ryan T Merrell; Margaret R Wrensch; Faith G Davis; Rose Lai; Sanjay Shete; Kenneth Aldape; Christopher I Amos; Donna M Muzny; Richard A Gibbs; Beatrice S Melin; Melissa L Bondy
Journal:  Sci Rep       Date:  2015-02-05       Impact factor: 4.379

5.  Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.

Authors:  Tobias Kessler; Felix Sahm; Jonas Blaes; Matthias Osswald; Petra Rübmann; David Milford; Severino Urban; Leonie Jestaedt; Sabine Heiland; Martin Bendszus; Anne Hertenstein; Philipp-Niclas Pfenning; Carmen Ruiz de Almodóvar; Antje Wick; Frank Winkler; Andreas von Deimling; Michael Platten; Wolfgang Wick; Markus Weiler
Journal:  Oncotarget       Date:  2015-10-13

6.  Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages.

Authors:  Guanzhang Li; You Zhai; Zheng Wang; Zhiliang Wang; Ruoyu Huang; Haoyu Jiang; Renpeng Li; Yuemei Feng; Yuanhao Chang; Tao Jiang; Wei Zhang
Journal:  Cancer Med       Date:  2019-12-18       Impact factor: 4.452

7.  Molecular Characterization of Differentiated-Resistance MSC Subclones by Single-Cell Transcriptomes.

Authors:  Andres Stucky; Li Gao; Shengwen Calvin Li; Lingli Tu; Jun Luo; Xi Huang; Xuelian Chen; Xiaoqing Li; Tiffany H Park; Jin Cai; Mustafa H Kabeer; Ashley S Plant; Lan Sun; Xi Zhang; Jiang F Zhong
Journal:  Front Cell Dev Biol       Date:  2022-03-09

8.  Linkage and related analyses of Barrett's esophagus and its associated adenocarcinomas.

Authors:  Xiangqing Sun; Robert Elston; Gary W Falk; William M Grady; Ashley Faulx; Sumeet K Mittal; Marcia I Canto; Nicholas J Shaheen; Jean S Wang; Prasad G Iyer; Julian A Abrams; Joseph E Willis; Kishore Guda; Sanford Markowitz; Jill S Barnholtz-Sloan; Apoorva Chandar; Wendy Brock; Amitabh Chak
Journal:  Mol Genet Genomic Med       Date:  2016-03-14       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.